Clinical impact of HLA class I expression in rectal cancer
Open Access
- 15 September 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Immunology, Immunotherapy
- Vol. 57 (5), 601-609
- https://doi.org/10.1007/s00262-007-0396-y
Abstract
To determine the clinical impact of human leukocyte antigen (HLA) class I expression in irradiated and non-irradiated rectal carcinomas.Keywords
This publication has 35 references indexed in Scilit:
- HLA expression and cancer – 14th IHIWS immunohistochemistry quality control exercise exchange resultsTissue Antigens, 2007
- Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapyThe Journal of Experimental Medicine, 2006
- Immunoselective Pressure and Human Leukocyte Antigen Class I Antigen Machinery Defects in Microsatellite Unstable Colorectal CancersCancer Research, 2005
- Systematic Review of Microsatellite Instability and Colorectal Cancer PrognosisJournal of Clinical Oncology, 2005
- Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β2‐microglobulin inactivation in MSI‐positive tumors and LMP7/TAP2 downregulation in MSI‐negative tumorsTissue Antigens, 2003
- Are there two sides to colorectal cancer?International Journal of Cancer, 2002
- Expression of HLA class I molecules in human first trimester and term placenta trophoblastCell and tissue research, 1996
- Frequency of abnormal expression of HLA-A,B,C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrenceInternational Journal of Cancer, 1991
- HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in Western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopyInternational Immunology, 1990
- Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfectionNature, 1985